RxNorm 2273113 NDC Crossover
tofacitinib 22 MG 24HR Extended Release Oral Tablet
Related NDC Codes to RxNorm Concept 2273113
The following NDC codes crossover to the RxNorm Concept 2273113. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
0069-0501 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0502 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1001 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1002 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1029 | Xeljanz | Tofacitinib | Solution | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
63539-012 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-016 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-501 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-502 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | ACTIVE |